Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes

Published:2020-08-03 Issue:10 Volume:21 Page:1244-1255
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Edner Natalie M.^ORCID,Heuts Frank,Thomas Niclas,Wang Chun Jing,Petersone Lina^ORCID,Kenefeck Rupert,Kogimtzis Alexandros,Ovcinnikovs Vitalijs,Ross Ellen M.,Ntavli Elisavet,Elfaki Yassin^ORCID,Eichmann Martin^ORCID,Baptista Roman,Ambery Philip,Jermutus Lutz,Peakman Mark,Rosenthal Miranda,Walker Lucy S. K.^ORCID

Funder

British Dietetic Association

RCUK | MRC | Medical Research Foundation

Rosetrees Trust

AstraZeneca

EC | Horizon 2020 Framework Programme

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://www.nature.com/articles/s41590-020-0744-z.pdf

Reference50 articles.

1. Blair, H. A. & Deeks, E. D. Abatacept: a review in rheumatoid arthritis. Drugs 77, 1221–1233 (2017).

2. Mease, P. J. et al. Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis. Ann. Rheum. Dis. 76, 1550–1558 (2017).

3. Brunner, H. I. et al. Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study. Arthritis Rheumatol. 70, 1144–1154 (2018).

4. Lenschow, D. J. et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145–1155 (1995).

5. Orban, T. et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet 378, 412–419 (2011).

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence;International Immunopharmacology;2024-10

2. Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial;Nature Medicine;2024-07-30

3. First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers;BMC Medicine;2024-06-21

4. TIGIT+Tfh show poor B-helper function and negatively correlate with SARS-CoV-2 antibody titre;Frontiers in Immunology;2024-05-29

5. Integrating Omics into Functional Biomarkers of Type 1 Diabetes;Cold Spring Harbor Perspectives in Medicine;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3